전이성 저분화 위장관췌장 신경내분비암종에서 화학요법과 면역요법의 실제 결과

Gujarathi 등(수요일)이 이 문제를 연구하였습니다.

www.synapsesocial.com/papers/69df2cb9e4eeef8a2a6b1e6e — DOI: https://doi.org/10.1002/cam4.71809

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer· 2018 · 3,455 citations
2. Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma.· 2023 · 1 citations
3. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases· 2017 · 270 citations
4. The 2019 WHO classification of tumours of the digestive system· 2019 · 4,025 citations
5. Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti–PD-1/PD-L1 therapy· 2017 · 52 citations